Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia (Q33501357)

27 July 2017

Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia (English)

1 reference

27 July 2017

0 references

1 reference

Cristina Tanaseanu

1

1 reference

27 July 2017

Slobodan Milutinovic

2

1 reference

27 July 2017

Petre I Calistru

3

1 reference

27 July 2017

Janos Strausz

4

1 reference

27 July 2017

Marius Zolubas

5

1 reference

27 July 2017

Valeriy Chernyak

6

1 reference

27 July 2017

Nathalie Dartois

7

1 reference

27 July 2017

Nathalie Castaing

8

1 reference

27 July 2017

Hassan Gandjini

9

1 reference

27 July 2017

C Angel Cooper

10

1 reference

27 July 2017

313 Study Group

11

1 reference

27 July 2017

language of work or name

1 reference

9 September 2009

1 reference

27 July 2017

BMC Pulmonary Medicine

1 reference

27 July 2017

9

1 reference

27 July 2017

44

1 reference

Creative Commons Attribution 2.0 Generic

27 July 2017

start time

9 September 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2466-9-44

0 references

cites work

Functional, biophysical, and structural bases for antibacterial activity of tigecycline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753558

Outpatient treatment of community-acquired pneumonia: evolving trends and a focus on fluoroquinolones.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753558

Guidelines for the management of adult lower respiratory tract infections

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753558

The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753558

Comparative antimicrobial susceptibility of respiratory tract pathogens

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753558

Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753558

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753558

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753558

Fluoroquinolone treatment of community-acquired pneumonia: a meta-analysis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753558

Community-acquired pneumonia in Europe: causative pathogens and resistance patterns.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753558

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753558

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753558

A prediction rule to identify low-risk patients with community-acquired pneumonia

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753558

Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753558

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753558

Epidemiological survey on incidence and treatment of community acquired pneumonia in Italy.

14 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-9-44

Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-9-44

Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000)

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-9-44

Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-9-44

The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-9-44

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-9-44

Antimicrobial activity of tigecycline against recent isolates of respiratory pathogens from Asian countries

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753558

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19740418

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19740418

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Guideline 'Diagnosis and treatment of community-acquired pneumonia' from the Dutch Thoracic Society]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19740418

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2466-9-44

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference

27 July 2017

1 reference